<p>B6J-WT BMCMCs were stimulated with 0–1,000 ng/ml (A) or 100 ng/ml (B) rmIL-33 in the presence of 40 µg/ml of several anti-ST2 mAbs or isotype control rat IgG for 24 h. The levels of IL-6 and IL-13 in the culture supernatants were determined by ELISA. Data show the mean + SEM (n = 3). *p<0.05 vs. rat IgG+IL-33. The expression of ST2 on the cell surface of BALB-WT and ST2<sup>−/−</sup> BMCMCs was determined using several distinct anti-ST2 mAb clones. Representative data by flow cytometry are shown (C). Shaded area indicates isotype-matched control IgG staining, and bold line indicates anti-ST2 mAb staining.</p
<p>BMCMCs obtained from B6J-WT mice (A) and B6J-WT and -TLR4<sup>−/−</sup> mice (B; left panels) and...
<p>The HCECs were exposed to IL-33 (10 ng/ml) with prior incubation in the absence or presence of is...
<p>The donor cells were isolated from popliteal lymph nodes 9 days after foot pad immunization of ST...
<p>(A, B) TGC-induced peritoneal macrophages derived from B6J-WT mice were cultured in the presence ...
<p>WT, TLR2/9<sup>-/-</sup> and MyD88<sup>-/-</sup> BMDMs were cultured with or without SR (0.05 mg/...
<p>Representative pictures of immunocytochemistry for IL-33, ST2, MyD88 and IRAK-1 are presented (<b...
<p>DCs were cultured in the presence of sTM from day 4. Neutralizing anti-mouse IL-10 mAb (clone: 2A...
(A and B) BMDMs were infected with Mab (MOI = 5) for the indicated time periods (A) Cell lysates was...
<p>A) Non-transgenic (non-Tg) and 11c.OVA mice were injected with αCD25 or isotype-control mAb (iso)...
<p>One week after the last immunization dose, spleen cells were obtained and cultured for cytokine m...
<p>(A) Mouse BMDCs were cultured for 24 h in the presence of LPS, MPL, or dLOS, and expression of CD...
<p>(A) Naïve CD8<sup>+</sup> T cells (3×10<sup>6</sup>/mL) were stimulated by anti-CD3/CD28 antibodi...
<p>Lymphocytes were prepared from naïve <i>Foxp3<sup>gfp</sup></i> mice and treated with anti-CD3 mA...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...
<p>(A) Quantitative real-time PCR was performed on RNA derived from wild-type and WASP15 Tg BMDMs fo...
<p>BMCMCs obtained from B6J-WT mice (A) and B6J-WT and -TLR4<sup>−/−</sup> mice (B; left panels) and...
<p>The HCECs were exposed to IL-33 (10 ng/ml) with prior incubation in the absence or presence of is...
<p>The donor cells were isolated from popliteal lymph nodes 9 days after foot pad immunization of ST...
<p>(A, B) TGC-induced peritoneal macrophages derived from B6J-WT mice were cultured in the presence ...
<p>WT, TLR2/9<sup>-/-</sup> and MyD88<sup>-/-</sup> BMDMs were cultured with or without SR (0.05 mg/...
<p>Representative pictures of immunocytochemistry for IL-33, ST2, MyD88 and IRAK-1 are presented (<b...
<p>DCs were cultured in the presence of sTM from day 4. Neutralizing anti-mouse IL-10 mAb (clone: 2A...
(A and B) BMDMs were infected with Mab (MOI = 5) for the indicated time periods (A) Cell lysates was...
<p>A) Non-transgenic (non-Tg) and 11c.OVA mice were injected with αCD25 or isotype-control mAb (iso)...
<p>One week after the last immunization dose, spleen cells were obtained and cultured for cytokine m...
<p>(A) Mouse BMDCs were cultured for 24 h in the presence of LPS, MPL, or dLOS, and expression of CD...
<p>(A) Naïve CD8<sup>+</sup> T cells (3×10<sup>6</sup>/mL) were stimulated by anti-CD3/CD28 antibodi...
<p>Lymphocytes were prepared from naïve <i>Foxp3<sup>gfp</sup></i> mice and treated with anti-CD3 mA...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...
<p>(A) Quantitative real-time PCR was performed on RNA derived from wild-type and WASP15 Tg BMDMs fo...
<p>BMCMCs obtained from B6J-WT mice (A) and B6J-WT and -TLR4<sup>−/−</sup> mice (B; left panels) and...
<p>The HCECs were exposed to IL-33 (10 ng/ml) with prior incubation in the absence or presence of is...
<p>The donor cells were isolated from popliteal lymph nodes 9 days after foot pad immunization of ST...